Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
Argus Health
QuintilesIMS
Deloitte
Mallinckrodt
McKesson
Healthtrust
Merck

Generated: April 21, 2018

DrugPatentWatch Database Preview

MONOPRIL Drug Profile

« Back to Dashboard

Drug patent expirations by year for MONOPRIL
Synonyms for MONOPRIL
(4S)-4-Cyclohexyl-1-(((R)-((S)-1-hydroxy-2-methylpropoxy)(4-phenylbutyl)phosphinyl)acetyl-L-proline propionate (ester), sodium salt
(4S)-4-Cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-L-proline Sodium Salt
01503944_FOSINOPRIL
1217528-56-7
88889-14-9
AB2000499
AC-6227
Acecor
Acenor-M
AK-73086
AKOS015888700
AKOS025117347
AN-10220
API0002766
AS-13178
AX8046004
BCP9000703
BR-73086
BS-1003
C30H45NNaO7P
CAS-88889-14-9
CHEBI:5164
CHEMBL3039596
CHEMBL3188382
CS-2454
D00622
DSSTox_CID_26621
DSSTox_GSID_46621
DSSTox_RID_81772
DTXSID7046621
Dynacil
Eliten
Eosinopril
FOSENOPRIL SODIUM
Fosinil
Fosinopril (sodium)
FOSINOPRIL SODIUM
Fosinopril sodium (Monopril)
Fosinopril sodium (USAN)
Fosinopril sodium [USAN:USP]
Fosinopril sodium [USAN]
Fosinopril sodium salt
Fosinopril sodium, >=98% (HPLC), powder
Fosinopril sodium, European Pharmacopoeia (EP) Reference Standard
Fosinopril sodium, United States Pharmacopeia (USP) Reference Standard
FOSINOPRIL?SODIUM
fosinoprilsodium
Fosinorm
Fosipres
Fositen
Fositens
Foziretic
H524
Hiperlex
HMS502N10
HY-B0382
J90058
KS-00000LIV
L-Proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, sodium salt, (1(S*(R*)),2alpha,4beta)-
L-proline, 4-cyclohexyl-1-[[[2-methyl-1-(1-oxopropoxy) propoxyl] (4-phenylbutyl) phosphinyl] acetyl]-, sodium salt, trans-
LS-118920
MFCD00865785
NCGC00167432-01
Newace
NW2RTH6T2N
s2095
Sapril
SC-17358
SCHEMBL40690
Secorvas
sodium (2S,4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylate
Sodium (2S,4S)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl
Sodium (2S,4S)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-
Sodium (2S,4S)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylate
sodium (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxy-propoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate
sodium fosinopril(1-)
SQ 28555
ST2419394
ST51051568
Staril
Tenso Stop
Tensogard
Tox21_112436
TVTJZMHAIQQZTL-WATAJHSMSA-M
UNII-NW2RTH6T2N

US Patents and Regulatory Information for MONOPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-002 May 16, 1991 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb MONOPRIL-HCT fosinopril sodium; hydrochlorothiazide TABLET;ORAL 020286-002 Nov 30, 1994 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-003 May 16, 1991 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-004 Mar 28, 1995 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for MONOPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-002 May 16, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-003 May 16, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-003 May 16, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-002 May 16, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Mallinckrodt
Queensland Health
Citi
Moodys
Chubb
Daiichi Sankyo
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.